Mazumdar-Shaw calls for biotech sovereignty in India

Why in news

Kiran Mazumdar-Shaw, founder of Biocon Ltd., advocated for 'biotech sovereignty' at the BioEconomy Conclave 2026 to secure India's control over biological data and AI models.

Background

The BioEconomy Conclave 2026 was organized by the Association of Biotechnology Led Enterprises (ABLE). Minister Priyank M. Kharge highlighted Karnataka as a hub for India's booming bioeconomy.

Facts for Prelims

• PostKiran Mazumdar-Shaw: Executive chairperson and founder of Biocon Ltd.
• BodyABLE: Association of Biotechnology Led Enterprises, a pan-India forum for the biotechnology sector.
• FactBiotech sovereignty involves control over biological data, AI models, and manufacturing platforms.

For Mains

Q. Discuss the significance of 'biotech sovereignty' in ensuring national health security and economic resilience in the era of AI-driven biotechnology.

Dimensions to cover in your answer

• Data security: Risks of unauthorized access to genomic data and proprietary biological datasets.
• Manufacturing autonomy: Reducing reliance on foreign platforms for critical healthcare manufacturing.
• AI ethics: Balancing rapid AI integration in biotech with safety and data privacy protocols.

Keywords: biotech sovereignty · health security · bioeconomy · data privacy · manufacturing platforms

More Science & Technology notes

• Healthcare workers’ use of GenAI platforms might risk leaks of sensitive patient data: study · 3 March 2026
• IMD issues advisory to overcome heatwave conditions in summer · 3 March 2026
• OpenAI amends Pentagon deal as Sam Altman admits it looks ‘sloppy’ · 3 March 2026
• Mandatory biometrics update: UIDAI finishes 1.2 crore biometric captures at schools · 3 March 2026
• Census 2027 to be first fully-digital exercise; House Listing Operations from May 11: Telangana CS · 3 March 2026
• KITE launches QR code-based mobile app for real-time tracking of higher secondary exams in Kerala · 3 March 2026

All Science & Technology current affairs →